这里有个材料。你可以猜一下......

Fortune 500 Pharma Cos Revenue/Profit/Employee Changes

（2010 over 2009)

Rank	Company	F500 rank	Revenue ($M)	% change from 2009	Profits ($M)	% change from 2009
1	Pfizer	31	67,809.0	35.6	8,257.0	-4.4
2	J&J	40	61,587.0	-0.5	13,334.0	8.7
3	Merck	53	45,987.0	67.7	861.0	-93.3
4	Abbott Labs	69	35,166.7	14.3	4,626.2	-19.5
5	Eli Lilly	115	23,076.0	5.7	5,069.5	17.1
6	BMS	131	19,484.0	-9.9	3,102.0	-70.8
7	Amgen	163	15,053.0	2.8	4,627.0	0.5
8	Gilead	299	7,949.4	13.4	2,901.3	10.1
9	Mylan	418	5,450.5	7.0	345.1	48.4
10	Allergan	457	4,919.4	9.2	0.6	-99.9
11	Biogen Idec	476	4,716.4	7.7	1,005.3	3.6
12	Genzyme	487	4,535.9	0.5	422.1	-0.0

Rank	Company	EPS growth (%)	RTI growth 00-10(%)	RTI growth 10 (%)	Employee Number	% Change from 2009
1	Pfizer	5.6	-6.0	0.6	110,600	-5.1
2	J&J	10.9	4.0	-0.6	114,000	-1.3
3	Merck	-20.8	-5.3	2.8	94,000	-6.0
4	Abbott Labs	5.2	3.1	-8.2	91,440	25.5
5	Eli Lilly	5.1	-6.3	3.8	38,350	-5.0
6	BMS	-2.7	-5.2	10.2	27,000	-3.6
7	Amgen	16.4	-1.5	-3.0	17,250	0.9
8	Gilead	N.A.	21.5	-16.2	4,000	3.3
9	Mylan	2.6	7.1	14.7	13,000	-7.1
10	Allergan	-45.4	4.4	9.3	9,200	10.8
11	Biogen Idec	44.4	0.6	25.3	4,850	2.1
12	Genzyme	8.8	4.7	45.3	10,100	-15.8